Status:
COMPLETED
Training With Mobile Application in Breast Cancer
Lead Sponsor:
Izmir Bakircay University
Collaborating Sponsors:
Ege University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Endocrine hormonal therapy (EHT) applied to avoid recurrence and metastasis of the breast cancer has also side effects which do not threaten life; however, it does negatively effects quality of life. ...
Detailed Description
Mobile devices have an increasing role for the patient care and its use in the field of oncology creates promising opportunities for supportive cancer care and patient education. Mobile applications w...
Eligibility Criteria
Inclusion
- Diagnosed with primary breast cancer,
- Non-metastatic,
- Hormone receptor positive (ER positive and/or PR positive)
- For whom adjuvant EHT was implemented at least for three months
Exclusion
- Diagnosed with secondary breast cancer,
- Metastatic,
- Hormone receptor negative (ER negative and/or PR negative)
Key Trial Info
Start Date :
January 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 17 2018
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04315012
Start Date
January 10 2018
End Date
April 17 2018
Last Update
April 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İzmir Bakırçay University
Izmir, Turkey (Türkiye), 35665